Background Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies
in order to enhance success rates, but the true benefit is actively debated. Growth hormone …

In a sequential crossover study of IVF conducted from 2002 to 2006, growth hormone (GH)
supplementation was assessed in poor-prognosis patients, categorized on the basis of past …

Background Many studies have demonstrated the benefits of the addition of growth hormone
(GH) to the controlled ovarian stimulation protocol in vitro fertilization (IVF) cycles in poor …

Meta-analysis demonstrated a benefit for the use of the adjunct GH, with a reduction in the
duration of ovarian stimulation required for oocyte retrieval, the collection of a greater …

Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …

Growth hormone (GH) is a peptide hormone secreted mainly by the anterior part of the
pituitary gland and plays a critical role in cell growth, development, and metabolism …

Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Purpose The aim of this meta-analysis was to evaluate the effect of growth hormone (GH)
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …

This open label randomized study aims to define the best protocol to be used with growth
hormone in poor responders, with comparison performed to delineate which protocol offers …

Poor ovarian response (POR) often means low success rates after in vitro fertilisation (IVF).
We aim to study the impact of a low-dose growth hormone (GH) supplementation in …